Medifast MED Estimates

NYSE MED
$12.13 -0.03 (-0.25%)
As of: Sep 9, 2026 · 3:59 PM EDT
Analyst Estimates

Medifast Inc Revenue Estimates

Periods 18
Next Period Q3 26
Consensus 69.16 M

Analysts expect Medifast Inc to report revenue of 69.16 M for Q3 26, against a range of 62.30 M to 76.02 M. The most recent reported quarter, Q2 26, came in at 76.38 M, a 9.7% beat against the 69.64 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 140.16 M119.00 M115.73 M105.56 M89.41 M75.10 M76.04 M76.38 M--------
High Estimate 150.16 M121.61 M129.96 M109.16 M93.90 M73.19 M70.99 M71.92 M76.02 M64.68 M69.53 M78.48 M67.67 M60.53 M63.22 M59.53 M
Low Estimate 136.52 M101.99 M117.88 M99.29 M76.98 M65.04 M60.66 M67.35 M62.30 M57.73 M62.90 M65.19 M59.70 M54.55 M56.08 M55.85 M
Consensus Estimate 143.34 M111.80 M123.92 M104.22 M85.44 M69.12 M65.82 M69.64 M69.16 M61.20 M66.22 M71.83 M63.69 M57.54 M59.65 M57.69 M
Analyst Estimates

Medifast Inc Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus -0.37

Analysts expect Medifast Inc to report earnings per share of -0.37 for Q3 26, against a range of -0.39 to -0.35. The most recent reported quarter, Q2 26, came in at -0.28, a 54.8% beat against the -0.62 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 0.350.10-0.030.40-0.21-0.55-0.19-0.28--------
High Estimate -0.19-0.13-0.24-0.18-0.35-0.76-0.51-0.57-0.35-0.12-0.14-0.08-0.34-0.20-0.17-0.18
Low Estimate -0.21-0.15-0.28-0.22-0.41-0.84-0.59-0.67-0.39-0.14-0.16-0.08-0.38-0.22-0.21-0.22
Consensus Estimate -0.20-0.14-0.26-0.20-0.38-0.80-0.55-0.62-0.37-0.13-0.15-0.08-0.36-0.21-0.19-0.20